Robyn P.M. Saw
University of Sydney(AU)The University of Sydney(AU)Royal Prince Alfred Hospital(AU)Mater Misericordiae Hospital(AU)Sydney Hospital(AU)Melanoma Institute Australia(AU)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses, CAR-T cell therapy research
Most-Cited Works
- → Whole-genome landscapes of major melanoma subtypes(2017)1,452 cited
- → Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy(2019)1,004 cited
- → Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma(2012)898 cited
- → BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact(2014)539 cited
- → Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial(2019)507 cited
- → CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment